DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Sanofi - Aventis Groupe
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medicines & Healthcare products Regulatory Agency (MHRA)
Medsafe (NZ)
Rilutek, also known by its generic name Riluzole, is a medication that has brought hope and relief to countless individuals facing the debilitating effects of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.
